🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

U.S. Sanctions Highlight Crypto’s Role in Drug Trafficking Network

Published 06/10/2023, 14:55
Updated 06/10/2023, 15:15
U.S. Sanctions Highlight Crypto’s Role in Drug Trafficking Network
BTC/USD
-

Coin Edition -

  • On October 3, 2023, the U.S. Treasury’s Office of Foreign Assets Control (OFAC) imposed sanctions.
  • These sanctions targeted individuals and companies involved in manufacturing and distributing dangerous drugs, including fentanyl and precursor chemicals.
  • Notably, the sanctions also extended to cryptocurrency addresses associated with the sanctioned entities.

The U.S. Treasury’s Office of Foreign Assets Control (OFAC) announced sanctions on October 3, 2023. The sanctions targeted several individuals and companies involved in the manufacturing and distribution of dangerous drugs, including fentanyl and precursor chemicals. Notably, these sanctions also extended to cryptocurrency addresses associated with the sanctioned entities.

Blockchain analytics firm Chainalysis published a report analyzing cryptocurrency activity related to recent US sanctions against a China-based drug trafficking network.

The entities at the center of the OFAC’s action form a sprawling drug trafficking network, based in China and involving one Canadian national and two Canadian businesses under their ownership.

According to the report, one striking aspect of this OFAC action is the connection between cryptocurrency and the drug trade. The cryptocurrency addresses associated with the sanctioned individuals and companies spanned the Bitcoin, Ethereum, and Tron blockchains. Notably, addresses on Ethereum and Tron primarily received stablecoins like USDT and USDC, aligning with the trend of using stablecoins for illicit transactions.

With the exception of addresses linked to a Valerian Labs, a Canadian company that describes itself as a “manufacturing facility that manufactures and bottles all types of beverages”, all of these addresses were hosted on a mainstream exchange referred to here as “Core Exchange.” Funds flowed into these addresses from both personal wallets and other mainstream exchanges, primarily six different ones.

According to the report, each of the five individuals received substantial sums of cryptocurrency, typically in consistent amounts. This pattern strongly suggests the sale of specific goods, in this case, fentanyl and its precursor chemicals.

For instance, a close examination of deposit addresses associated with Shen Xianbiao, one of the sanctioned individuals and a part-owner of Jinhu Minsheng Pharmaceutical Machinery, revealed that most transactions from personal wallets fell within the narrow range of $5,000 to $5,500 worth of cryptocurrency.

Furthermore, these addresses received substantial amounts from darknet markets, indicating that they may represent vendors purchasing drugs or precursor chemicals from these labs for subsequent resale.

The post U.S. Sanctions Highlight Crypto’s Role in Drug Trafficking Network appeared first on Coin Edition.

Read more on Coin Edition

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.